Wed.Jan 15, 2025

article thumbnail

STAT+: Health AI investments are off to a roaring start in 2025

STAT

Over the last week, companies developing artificial intelligence products for health care have announced a series of impressive fundraises that set the tone for what could be a banner year for AI investment. Timed to the J.P. Morgan Healthcare conference, the announcements include $245 million for Innovaccer, a health care data company that’s increasingly focused on AI, $141 million for Hippocratic AI, a company that develops generative AI agents to help with clinical tasks, and $105 mill

article thumbnail

What to know before buying compounded semaglutide online

The Checkup by Singlecare

If youre looking to reduce your body weight and body mass index (BMI), your healthcare provider may prescribe a GLP-1 medication, such as Wegovy (semaglutide), as part of your weight-loss program. However, due to a national shortage of Wegovy and Ozempic (the Type 2 diabetes treatment with the same active ingredient), patients are looking for alternatives.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: International monitor recommends end to some monkey shipments from Cambodia

STAT

The officials who oversee an international treaty governing endangered species recommended suspending shipments of long-tailed macaques — which are regularly used in medical research — from Cambodia. The move also follows controversy over shipments involving Charles River Laboratories, one of the largest contract research organizations serving the pharmaceutical industry.

article thumbnail

Ensuring packaging integrity of frozen biopharmaceutical products

European Pharmaceutical Review

A study has investigated the challenges of freezing biological drug products with vials as a primary packaging container. In their study, Henle et al. assessed the suitability of different vial qualities in relation to the thermally induced mechanical stresses experienced during frozen drug product preparation and storage. The researchers stated that in recent years, novel vial types for special applications of parenteral drug products have entered the market.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: Pharmalittle: We’re reading about FTC criticizing PBMs, a NIH policy on access to medicines, and more

STAT

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appetizing. And what better way to make the time fly than to keep busy.

article thumbnail

Testosterone Replacement Therapy Azmiro Now Available in US

Drug Topics

The therapy is the first and only prefilled testosterone cypionate injection approved by the FDA.

FDA

More Trending

article thumbnail

Review: Antiviral Medications for Nonsevere Influenza

Drug Topics

There are a lack of data available on the optimal antiviral medication for nonsevere flu.

article thumbnail

STAT+: At JPM, biotech industry expresses excitement — and some anxiety — about therapies from China

STAT

SAN FRANCISCO — Are we entering a world in which all of the exciting new therapeutics come from China? That question and variations of it could be heard at coffee meetings and late-night cocktail parties this week during the J.P. Morgan Healthcare Conference.  Just days before planes full of biopharma executives and investors touched down in San Francisco, a flurry of companies launched with drug candidates from China.

article thumbnail

What to expect in the sequel to Medicare’s drug price negotiation program

PharmaVoice

CMS is expected to publish up to 15 drugs for the second cycle of the program by Feb. 1, and these are some of the drugs most likely to make the list.

article thumbnail

How the FDA’s new nutrition labels could prod the food industry to get healthier 

STAT

A new government proposal to display nutritional labels on the front of food packaging is aimed at helping Americans make more informed choices about what they eat. An eventual side effect, research and expert commentary suggests, could be nudging the food industry to make healthier food, too. The Food and Drug Administration on Tuesday unveiled a proposal, long in the works , for a mandatory food labeling system that it says is intended to combat chronic diseases, including heart disease, cance

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Sustainable Treatment for Low Back Pain Key in Reducing Opioid, Opioid-Sedative Prescriptions

Drug Topics

Older patients were more likely to receive opioid-sedative coprescriptions to treat low back pain.

article thumbnail

New FTC Report Finds PBMs Increased Prices for Specialty Cancer, HIV Generic Drugs to Generate Billions in Revenue

Pharmacy Times

Building on a previous report that revealed corrupt business practices among the big 3 PBMs, a second interim report finds that PBMs heightened prices for important specialty generic drugs to increase their profit margins.

article thumbnail

Sustaining Positivity Among Students, Professionals Critical for Pharmacy’s Future

Drug Topics

A conversation with David Nau, PhD, professor of social and administrative pharmacy, and director of assessment at Ohio Northern University.

article thumbnail

Key Drugs to Watch for Community Pharmacy in 2025

Pharmacy Times

These drugs are set to revolutionize their respective disease states in 2025.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Q&A: The Pharmacist’s Ability to Provide Nutritional Guidance

Drug Topics

Sarah Gray, PharmD, GAICD, explored the unique combination of being both a pharmacist and nutritionist.

article thumbnail

STAT+: Biden administration and Gilead settle long-running battle over patents for HIV PrEP pills

STAT

After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a pair of HIV prevention pills in a case that raised questions about the extent to which government-funded research should lead to affordably priced medicines. At issue was a battle over patents for Truvada and a newer, upgraded version called Descovy — two highly effective and lucrative medications — as well as the role played by the federal government in makin

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

The new notice of proposed rulemaking adheres to calls from Congress and industry for the agency to create a special telemedicine registration system. Its three-tiered approach could cost telehealth companies over $40,000 to prescribe controlled substances in all 50 states.

article thumbnail

Wrapping up the J.P. Morgan Healthcare Conference

PhRMA

This year at J.P. Morgan Healthcare Conference was one to remember.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

The third day of the annual J.P. Morgan Healthcare Conference brings presentations from GoodRx, Health Catalyst, Talkspace and Salesforce along with Medicare Advantage insurers Alignment Healthcare and Clover Health.

article thumbnail

Demoting BMI, a new food label from the FDA, and risks of even moderate drinking

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Yesterday, I read a dispassionate explanation in the New York Times of how to become a better swimmer. I’m already a proficient swimmer, so I knew all of the lessons. (Keep your head looking down , guys!) But it reminded me of a favorite personal essay , also in the Times.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Staffing shortages, administrative burdens and opportunities for technology are top of mind for behavioral health organizations, a new survey reveals.

article thumbnail

Data Show Significant Genetic Correlations Between PTSD and Various Cardiovascular Diseases

Pharmacy Times

Posttraumatic stress disorder is found to be associated with coronary artery disease, hypertension, and heart failure.

article thumbnail

Keros pulls study of Winrevair rival after safety signal

pharmaphorum

Adverse events have led Keros to abandon a phase 2 trial of pulmonary arterial hypertension drug cibotacept, a would-be rival to MSD's Winrevair

article thumbnail

FDA Bans Red Dye No. 3 in Food and Drugs, Citing Cancer Risks

Pharmacy Times

Studies shows that Red Dye No. 3 was associated with tumor growth in male rats.

FDA
article thumbnail

Obesity needs a new definition, says global commission

pharmaphorum

Experts think the current way of defining obesity based on BMI isn't nuanced enough to gauge health and the need for weight-loss therapies.

article thumbnail

A Silent Killer: The Overlooked Risk of Radon in Lung Cancer

Pharmacy Times

Radon is a tasteless, odorless radioactive gas associated with DNA damage and high genomic tumor instability.

article thumbnail

FTC doubles down on PBM criticism in new report

pharmaphorum

A new FTC report claims that pharmacy benefit managers generated $7.3bn by marking up specialty generics used to treat diseases like cancer and HIV.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Consolidation's negative impact on prices, access and quality "were voiced vociferously by respondents," while private equity's influence on healthcare providers "seems to have struck a nerve in the public," federal agencies wrote in a new report.

article thumbnail

Sling shoots at thyroid eye disease with its oral therapy

pharmaphorum

Amgen's thyroid eye disease blockbuster Tepezza, given by infusion, is facing competition from an oral alternative from Sling Therapeutics

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Federal departments said they'll continue allowing plans to calculate qualifying payment amounts using a "good faith, reasonable interpretation" of court rulings and prior guidance.

article thumbnail

Lilly trims sales forecast on weaker obesity/diabetes growth

pharmaphorum

Eli Lilly has revised its revenue forecast for 2024 after seeing weaker-than-expected growth for its diabetes and obesity therapies.

article thumbnail

Metronomic Capecitabine With an Aromatase Inhibitor Demonstrates Safety, Efficacy in Treatment of HR+, HER2– Metastatic Breast Cancer

Pharmacy Times

The approach favors administration of frequent low-dose chemotherapy to reduce toxicities and optimize outcomes.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Changes to the Hart-Scott-Rodino Form finalized in October would increase the paperwork burden on merging entities and are set to go into effect Feb. 10.